Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Oncology

Hepatobiliary/Pancreas

Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): Long-term results of a multicentre, randomised, controlled, phase 3 trial

The Lancet Oncology | Feb 07, 2020 Hepatobiliary/Pancreas

Aggressive multimodal treatment and metastatic colorectal cancer survival

Journal of the American College of Surgeons | Feb 07, 2020 Hepatobiliary/Pancreas

Development and validation of a laboratory risk score (LabScore) to predict outcomes after resection for intrahepatic cholangiocarcinoma

Journal of the American College of Surgeons | Feb 07, 2020 Hepatobiliary/Pancreas

Pancreatitis and pancreatic cancer in patientes treated with Dipeptidyl Peptidase-4 inhibitors: An extensive and updated meta-analysis of randomized controlled trials

Diabetes Research and Clinical Practice | Feb 06, 2020 Hepatobiliary/Pancreas

Relationship between insurance type at diagnosis and hepatocellular carcinoma survival

Cancer Epidemiology, Biomarkers & Prevention | Feb 05, 2020 Hepatobiliary/Pancreas

GALAD score detects early hepatocellular carcinoma in an international cohort of patients with nonalcoholic steatohepatitis

Clinical Gastroenterology and Hepatology | Feb 02, 2020 Hepatobiliary/Pancreas

A randomized, placebo-controlled, double-blind study of minocycline for reducing the symptom burden experienced by patients with advanced pancreatic cancer

Journal of Pain and Symptom Management | Feb 02, 2020 Hepatobiliary/Pancreas

Tumor-derived peptidoglycan recognition protein 2 predicts survival and antitumor immune responses in hepatocellular carcinoma

Hepatology | Feb 01, 2020 Hepatobiliary/Pancreas

Time spent away from home in the year following high-risk cancer surgery in older adults

Journal of the American Geriatrics Society | Jan 30, 2020 Hepatobiliary/Pancreas

Microscopic size measurements predict outcomes in post-neoadjuvant resections of pancreatic ductal adenocarcinoma (PDAC)

Histopathology | Jan 29, 2020 Hepatobiliary/Pancreas

« Prev 1 … 30 31 32 33 34 … 118 Next »

Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): Long-term results of a multicentre, randomised, controlled, phase 3 trial

Aggressive multimodal treatment and metastatic colorectal cancer survival

Development and validation of a laboratory risk score (LabScore) to predict outcomes after resection for intrahepatic cholangiocarcinoma

Pancreatitis and pancreatic cancer in patientes treated with Dipeptidyl Peptidase-4 inhibitors: An extensive and updated meta-analysis of randomized controlled trials

Relationship between insurance type at diagnosis and hepatocellular carcinoma survival

GALAD score detects early hepatocellular carcinoma in an international cohort of patients with nonalcoholic steatohepatitis

A randomized, placebo-controlled, double-blind study of minocycline for reducing the symptom burden experienced by patients with advanced pancreatic cancer

Tumor-derived peptidoglycan recognition protein 2 predicts survival and antitumor immune responses in hepatocellular carcinoma

Time spent away from home in the year following high-risk cancer surgery in older adults

Microscopic size measurements predict outcomes in post-neoadjuvant resections of pancreatic ductal adenocarcinoma (PDAC)

MD Clip on Recent Advances in Lipid Management with Dr Gopinath

Article: Anti-Inflammatory Diets for Pain and Arthritis Management

Article on Strategies to Reduce Antibiotic Misuse and Address Antimicrobial Resistance

The 1 food geriatricians avoid to live a long, healthy life

Many young adults have high long-term risk for cardiovascular disease, study finds

Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): Long-term results of a multicentre, randomised, controlled, phase 3 trial

Aggressive multimodal treatment and metastatic colorectal cancer survival

Development and validation of a laboratory risk score (LabScore) to predict outcomes after resection for intrahepatic cholangiocarcinoma

Pancreatitis and pancreatic cancer in patientes treated with Dipeptidyl Peptidase-4 inhibitors: An extensive and updated meta-analysis of randomized controlled trials

Relationship between insurance type at diagnosis and hepatocellular carcinoma survival

GALAD score detects early hepatocellular carcinoma in an international cohort of patients with nonalcoholic steatohepatitis

A randomized, placebo-controlled, double-blind study of minocycline for reducing the symptom burden experienced by patients with advanced pancreatic cancer

Tumor-derived peptidoglycan recognition protein 2 predicts survival and antitumor immune responses in hepatocellular carcinoma

Time spent away from home in the year following high-risk cancer surgery in older adults

Microscopic size measurements predict outcomes in post-neoadjuvant resections of pancreatic ductal adenocarcinoma (PDAC)

MD Clip on Recent Advances in Lipid Management with Dr Gopinath

Article: Anti-Inflammatory Diets for Pain and Arthritis Management

Article on Strategies to Reduce Antibiotic Misuse and Address Antimicrobial Resistance

The 1 food geriatricians avoid to live a long, healthy life

Many young adults have high long-term risk for cardiovascular disease, study finds

Select Specialty

Select Topic